# Filing your study with the Ethical Committee UZ/KU Leuven

## Step 1: Register your study at the UZ Leuven Clinical Trial Center (CTC)

1. **Fill in [this online form](https://www.uzleuven.be/en/register-a-study)** in order to register your study in the UZ/KU Leuven central clinical research database.
You can find a user guide on how to do this [here](https://gbiomed.kuleuven.be/english/ctc/cr-gen-ug-001_user-guide-for-registering-a-study-in-the-uz-ku-leuven-central-clinical-research-database).
At the minimum, you will need to indicate the study type and upload your research protocol.

2. After submission of the registration form to the CTC, your study will be **assigned a study number** (the famous S-number), which will be sent to the PI, the identified study contact person at UZ/KU Leuven and the applicant (you) via e-mail.
You will need this number for your application to the EC.

3. As soon as an S-number is assigned, **supporting UZ Leuven departments** (e.g., radiology) from which study-specific support will be required should be contacted, using the relevant [forms](https://gbiomed.kuleuven.be/english/ctc/supporting-hospital-departments-for-public-ctc-website/application-forms-for-supporting-hospital-departments). You can find more info on how to do this on this [flowchart](https://gbiomed.kuleuven.be/english/ctc/supporting-hospital-departments-for-public-ctc-website/3-2-how-to-contact-supporting-departments-after-obtaining-s-nr).
In addition, the [**UZ Leuven GDPR questionnaire**](https://www.uzleuven.be/en/ctc-gdpr-questionnaire) or [**KU Leuven PRET questionnaire**](https://www.groupware.kuleuven.be/sites/pret/Pages/default.aspx) should be completed. Both the form and the questionnaire are requirements for admissibility to submit your study to the EC.

4. After the internal UZ Leuven stakeholders have reviewed all the documentation and no questions arise during the review process, you will obtain **approval from the CTC** via an automated validation email. Hooray, you are now ready to submit your study for EC review!

For more info about the CTC, navigate [here](https://gbiomed.kuleuven.be/english/ctc). If you have questions, you can contact them [via email](mailto:ctc@uzleuven.be) or phone (+32 16 34 19 98).

## Step 2: Apply for EC approval

Most likely, you are seeking to get ethical approval for a **prospective monocentric (academic) study**, for which you can find the application guidelines [here](https://www.uzleuven.be/nl/ethische-commissie-onderzoek/prospectieve-studies/experiment/academisch-monocentrisch).
(If you are planning to conducting a different type of study, please start [here](https://www.uzleuven.be/nl/ethische-commissie-onderzoek) and navigate to the correct study type to find the corresponding info on the application process.)

For a valid application, you are required to upload the following components:

!!! warning "Language of documentation"
 All the documentation needs to be written in Dutch, except for the research protocol and the translated versions of the ICFs.

1. **Accompanying letter signed by the PI**

    - Ask for approval (specify the study type) and add a short description of the goals of the project
    - Specify where (national/international) and by whom the study will be conducted (your affiliation)
    - Describe the participant group, the recruitment and reimbursement procedure
    - Specify that the informed consent forms will be signed prior to participation
    - Describe the discomfort for the participant and the procedure in case of accidental findings
    - State (in name of the PI) that:
        - there are no scientific or ethical concerns noted and the study can be executed as described in the protocol
        - no research costs will be charged to the patient, the health insurance or the hospital
    - Refer to the attached documents

2. **Research protocol including a summary of the protocol in Dutch**

    - Study title, location, rationale and design (incl. study background and objectives)
    - Description of the end points (= primary and secondary outcomes which the study aims to measure)
    - Research method (e.g., behavioral/psychophysical tests and/or neuroimaging)
    - Participant group(s) (incl. inclusion and exclusion criteria)
    - Statistical analysis (incl. software that will be used and sample size calculations)
    - Include an explanation for the sample size, referring to a power analysis
    - In general for typical fMRI studies, a reference to the paper of Friston (2012) is sufficient
    - Any no-fault insurance
    - Quality assurance
    - Direct access to source data
    - Ethical (and any regulatory) approval
    - Method of data processing
    - Publication policy
    - References
    - Each page of the protocol should be numbered ("page X"), with a footer recording the version      number and date.

3. **Participant recruitment**

    - Provide a recruitment summary that describes the procedure that will be used to contact and recruit the study population described in the protocol: where, how, by whom.
    - Make sure to include a justification for the potential recruitment of participants who are unable to give their consent. This info should be provided in the recruitment summary.
    - If recruitment materials (posters, brochures, advertisements, website, etc.) are used, they also have to be submitted under this section. You can read the guidelines on advertising/recruting [here](https://www.uzleuven.be/nl/ethische-commissie-onderzoek/templates-en-interne-richtlijnen-bij-starten-van-dossier-bij-ec-onderzoek/adverterenrekruteren-voor-klinische-studies-richtlijnen-ec-onderzoek).
    - Each piece of recruitment material should clearly state the version number and date.

4. **Informed consent forms (ICFs)** (in English and in Dutch)

    - The EC requires the use of ICF templates which already include information regarding the legal basis for data processing chosen by UZ/KU Leuven (i.e., "public interest", cf. Article 6 of the GDPR), include the necessary contact details of the insurance company, etc. You can find them [here](https://www.uzleuven.be/nl/ethische-commissie-onderzoek/templates-en-interne-richtlijnen-bij-starten-van-dossier-bij-ec-onderzoek/informed-consent-formulier-icf-opstellen-voor-ec-onderzoek) (navigate to "niet-EudraCT studies").
    - The ICF should be written in clear and understandable language and consist of the following subsections (in a single document):

        1. Essential information to make the decision to participate, such as a clear description of the study project (context, objectives, methodology and procedure), a brief but clear explanation of the participant's rights (voluntary participation, confidentiality, safety precautions, insurance, etc.) and a description of the risks and benefits. Make sure to also include contact details of the PI such that the candidate has a contact point for further questions.
        2. The consent form
        3. Additional information (appendices) that does not immediately play a role in the decision-making process, such as more detailed information on the study visits (i.e., the number, frequency and content) or on the participant's rights.

    - Each page in the ICF should be numbered ("page X") and mention the full study title and version number and date of the ICF.
    - If the application is covering both behavioral as well as neuroimaging experiments, provide two separate ICFs.

5. **Resume of the Principal Investigator** (dated and signed)

    - The CV should include sufficient information to allow the EC to assess the competence of the PI (i.e., education, current position, professional experience, relevant experience in clinical studies, etc.). [This template](https://www.uzleuven.be/nl/media/17b61417-889b-478e-b4da-06bc120feab1/CV%20hoofdonderzoeker%2028062022.docx) can be used.
    - The CV should also mention a Good Clinical Practice (GCP) certificate, including the date of certification (no more than 3 years old) and the organization that issued the certificate. GCP training is mandatory for all PIs.

6. A pdf-version of the completed [**UZ Leuven GDPR questionnaire**](https://www.uzleuven.be/en/ctc-gdpr-questionnaire) or the accepted [**KU Leuven PRET questionnaire**](https://www.groupware.kuleuven.be/sites/pret/Pages/default.aspx)

7. [**Proof of "no fault" insurance**](https://admin.kuleuven.be/sab/vz/en/public-liability#section-4), which you can request by sending an email to *<liability@kuleuven.be>* or if UZ/KU Leuven is the sponsor of the study, you can find insurance certificates [here](https://www.uzleuven.be/en/ethics-committee-research/explanatory-notes/proof-no-fault-insurance-ec-research)
8. **Good clinical practice certificates**
   - Good Clinical Practice (GCP) certificates are required for each of the researchers to be involved in data collection, prior to data collection beginning. GCP certificates are required for PIs when submitting an ethics application. You can find information and registration for training [here](https://gbiomed.kuleuven.be/english/ctc/intern/ctc-academy/ich-gcp-e6-r2-training-certification)

9. **Suitability/agreement of the relevant supporting UZ Leuven departments**

Once you have written all the necessary documents, you can file your application [here](https://www.uzleuven.be/nl/ethische-commissie-onderzoek/aanvraagformulier-voor-studie-bij-ec-onderzoek) by uploading all necessary information. Please note that only 1 (zip)file per component is allowed.

---

# Filing an amendment with Ethical Committee UZ/KU Leuven
For UZ/KU Leuven there are two types of amendment. Detailed information which option to choose can be found [here](https://www.uzleuven.be/en/ethics-committee-research/supplement-approved-study-ec-research/submitting-amendments-ec-research):
- Substantial amendments
- Amendments for participation of additional centres in a previously approved study

**Substantial amendments**

Requirements for submission (for detailed information, see [here](https://www.uzleuven.be/en/ethics-committee-research/experiment/submitting-amendments-ec-research-experiment/substantial-amendments):
- Cover letter of the PI
- Amended documents with changes marked via track changes (**must have updated version numbers and dates**)
- **IF** changes to ICF are needed, it is recommended to use an **ICF Addendum for ongoing participants** The ICF addendum includes only the changes or new information, making it more clear for the participant than a revised ICF with marked changes.
- When submitting provide the name, telephone and email address of contact within UZ Leuven/KU Leuven (other than the investigator) for follow-up of the file.
- **Submission to be made by electronic submission via Eudralink, via Liquidfiles or by email (<ecstaf@uzleuven.be>)**

**Amendments for participation of additional centres in a previously approved study**
Requirements for submission (for detailed information, see [here](https://www.uzleuven.be/en/ethics-committee-research/experiment/submitting-amendments-ec-research-experiment/participation-additional-centres-previously-approved-research)

- Cover letter of the PI
- Written confirmation of the sponsor that the file was simultaneously submitted at all new centres
- Details of the added local ethics committees (name of contact, address, telephone, fax, email address)
- The name of the local principal investigator(s) for whom the local ethics committee issues an opinion
- Contracts of all added centres. In the event that the contracts are identical for all centres, it is sufficient to submit one model contract with written declaration from the client that all contracts are identical for all centres, including compensations.
- Concise CV(s) of the investigator(s) of the added centres
- Name and address (preferably in Belgium) of a contact at the company to whom the invoice can be sent
- Name, tel/fax, email of contact at UZ Leuven/KU Leuven (other than the investigator) for follow-up of the file
- **Submission to be made by electronic submission via Eudralink, via Liquidfiles or by email (<ecstaf@uzleuven.be>)**
---

<!--
__TODO__: [Klara] Check whether this still applies --> "If the medical ethical committee has an issue with the principal investigator not being connected with UZ Leuven (e.g. in case the PI is a professor at the Faculty of Psychology and Educational Sciences); report this to Prof. Dr. Pol GhesquiÃ¨re."
__TODO__: [Klara] Update this page and make a bit more to the point
-->
